BiotechTube
Home/Sedia Biosciences/Roger I. Gale, M.E.
RI

Roger I. Gale, M.E.

Chief Executive Officer, President & Co-Founder

Sedia Biosciences

Therapeutic Areas

Infectious DiseaseHIV/AIDS

Sedia Biosciences Pipeline

DrugIndicationPhase
HIV Recency AssaysHIV Infection Recency (Incidence Monitoring)Commercial
Rapid POC AssaysInfectious Diseases & Other MarkersDevelopment
Specimen Collection DevicesSpecimen Stabilization & TransportDevelopment/Commercial

Leadership Team at Sedia Biosciences

RM
Ronald Mink, Ph.D.
Advisor, Science and Technology & Co-Founder
RJ
Ritesh Jaiswal
Chief Business Officer
AL
Alan Lofquist, Ph.D.
Vice President, R&D
View full Sedia Biosciences profile